{{Rsnum
|rsid=2975766
|Gene=CAPN10
|Chromosome=2
|position=240598657
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.01331
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 4.6 | 95.4
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 1.9 | 98.1
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 5.2 | 94.8
| LWK | 1.0 | 5.7 | 93.3
| MEX | 0.0 | 7.1 | 92.9
| MKK | 0.0 | 0.7 | 99.3
| TSI | 0.0 | 11.2 | 88.8
| HapMapRevision=28
}}{{Venter SNP
|rsid=2975766
|allele=G
|frequency=0.975
|uid=1103658409726
|type=homozygous_SNP
|hugo=CAPN10
|ensembl gene=ENSG00000142330
|ensembl transcript=ENST00000270361
|sift=TOLERATED
|disease=Defects in CAPN10 are associated with type II diabetes (NIDDM) (MIM:125853).
}}

{{PMID Auto
|PMID=19416960
|Title=Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.
|OA=1
}}

{{GET Evidence
|gene=CAPN10
|aa_change=Ile666Val
|aa_change_short=I666V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2975766
|overall_frequency_n=10446
|overall_frequency_d=10674
|overall_frequency=0.97864
|n_genomes=56
|n_genomes_annotated=0
|n_haplomes=111
|n_articles=0
|n_articles_annotated=0
|nblosum100=-4
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}